Gastrointestinal Talaromyces marneffei infection in a man with AIDS: A case report

Renping Peng1, Zhipeng Peng2, Minhong Mou3

  • 1Department of Endoscopy, The Fourth People's Hospital of Nanning, Nanning, China.

Medicine
|April 7, 2023
PubMed
Abstract

Insights

Talaromyces marneffei infection, though rare in the stomach, can cause gastric ulcers in AIDS patients. Early diagnosis and combined antifungal and proton pump inhibitor treatment led to a successful outcome in this case.

Area of Science:

  • Medical Mycology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Gastric Talaromyces marneffei infection is uncommon, with most reported cases involving the intestines.
  • Disseminated talaromycosis presents a diagnostic challenge, particularly when affecting the gastrointestinal tract.

Observation:

  • A 49-year-old male with HIV presented with gastrointestinal symptoms including abdominal distension and poor appetite.
  • Endoscopy revealed multiple gastric and intestinal ulcers; Helicobacter pylori infection was excluded.
  • Metagenomic next-generation sequencing confirmed Talaromyces marneffei in gastric ulcer tissue.

Findings:

  • The patient received sequential antifungal therapy (amphotericin B followed by itraconazole) and a proton pump inhibitor.
  • Combined treatment resulted in significant clinical improvement, with resolution of gastrointestinal symptoms.
  • The patient remained symptom-free during a 1-year follow-up period.

Implications:

  • Clinicians in endemic regions should consider Talaromyces marneffei infection in AIDS patients with unexplained gastric ulcers.
  • Prompt diagnosis and appropriate antifungal treatment are crucial for managing disseminated talaromycosis.
  • This case highlights the importance of advanced diagnostic techniques like metagenomic sequencing for rare fungal infections.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
46
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
295
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
387
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
286